Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Johnson and Johnson
McKinsey
Cipla
Boehringer Ingelheim
Moodys
QuintilesIMS
Harvard Business School
AstraZeneca

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050536

« Back to Dashboard

NDA 050536 describes ERYC, which is a drug marketed by Mayne Pharma, Parke Davis, Warner Chilcott Llc, Hospira, and Johnson And Johnson, and is included in seven NDAs. It is available from one supplier. Additional details are available on the ERYC profile page.

The generic ingredient in ERYC is erythromycin. There are one hundred and two drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 050536
Tradename:ERYC
Applicant:Mayne Pharma
Ingredient:erythromycin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 050536
Suppliers and Packaging for NDA: 050536
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ERYC erythromycin CAPSULE, DELAYED REL PELLETS;ORAL 050536 NDA AUTHORIZED GENERIC Mayne Pharma Inc. 68308-250 N 68308-250-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, DELAYED REL PELLETS;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Healthtrust
Argus Health
AstraZeneca
Johnson and Johnson
McKesson
McKinsey
US Department of Justice
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.